Team leader Professor Bao-Ting Zhu is an expert on molecular and cellular studies of cellular events and drugs. He was selected into the National Thousand-Talents-Plan in 2012 and currently serves as Professor and Associate Dean of the School of Science and Engineering at CUHK (SZ).
團隊帶頭人朱寶亭教授是細胞和分子藥理學專家，2012年入選國家「千人計劃」（長期項目），現任港中大（深圳）理工學院副院長及教授。
Professor Zhu obtained his B.M. and M.S. degree from Fudan University Shanghai Medical College in 1985 and 1988, respectively. He obtained his PhD degree in pharmacology from University of Texas in 1992. In 1998, he assumed an independent faculty position as an Assistant Professor at the University of South Carolina. While working there, he received promotions to Tenured Full Professor in 2004, and endowed Distinguished Professor in 2005. A year later, he was appointed as the Director for the Department of Basic Pharmaceutical Sciences. In 2007, Prof. Zhu joined the University of Kansas School of Medicine to assume a prominent academic position as the endowed William W. Abercrombie Distinguished Professor in Cancer Research.
朱寶亭教授於1985年、1988年先後就讀於復旦大學醫學院並獲得醫學學士學位和藥理學碩士學位，1992年獲美國德州大學藥理學博士學位，1998年受聘美國南卡羅來納大學任助理教授，2004年晉升為藥理學終身教授，2005年晉升為藥理學冠名傑出教授，2006年任南卡羅來納州藥學院系主任，2007年任堪薩斯大學醫學院任腫瘤研究終身冠名傑出教授，同時任藥理學終身教授及堪薩斯大學癌症中心腫瘤生物學研究組帶頭人。
One of Prof. Zhu’s research interests centers around the better understanding of the biochemical, molecular, and cellular mechanisms underlying the pharmacological actions of steroid hormones and drugs. In recent years, Prof. Zhu has also developed a strong interest in studying the memory and cognitive functions of the brain, in an effort to better understand the molecular and chemical mechanisms underlying these vital neuronal functions. Professor Zhu has authored or co-authored over 130 publications with 7000 citations. Professor Zhu has been invited to edit or review papers for more than 30 international journals, including Cancer Res, Endocrinology, JPET and PNAS. He is also a reviewer of several research foundations, including NIH, NSF, SNSF, and The Research Grants Council of Hong Kong.
朱寶亭教授的研究領域涵蓋基礎分子藥理學、腫瘤藥理學及疾病分子機理學。主要研究重點是甾體激素受體拮抗劑的設計、合成和藥理功能的研究，已在國際上以第一或通訊作者發表了近130餘篇高質量學術論文，引用次數7000次。朱寶亭教授應邀擔任Cancer Res、Endocrinology、JPET、PNAS等30餘種國際專業雜誌審稿者或編委，任美國國立衛生研究所（NIH）、美國國立自然科學基金（NSF）、瑞士國家科學基金會以及香港研究資助局等科研基金的評審委員。